| Ytd | 105.26% | |
| 1y | -23.61% |
| Open | 7.03 | Prev Close | 7.03 | Low | 7.01 | High | 7.03 | Mkt Cap | 575.59M |
| Vol | 0.00 | Avg Vol | 1.57M | EPS | -2.28 | P/E | -3.08 | Forward P/E | -4.05 |
| Beta | 2.10 | Short Ratio | 2.59 | Inst. Own | 83.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 6.95 | 200-d Avg | 4.78 | 1yr Est | 7.17 |
ACCD News
RALEIGH, N.C.--(BUSINESS WIRE)--Vontier (NYSE: VNT), a leading global provider of critical technolog
American Radium Society Honors Thomas Buchholz, M.D., with 2026 Gold Medal Award American Radium Soc
/PRNewswire/ -- Defining Wellness Centers (www.definingwellness.com) today announced that veteran he
HONG KONG, Jan. 23, 2026 (GLOBE NEWSWIRE) -- CoinEx has been recognized by International Business Ma
Fort Walton Beach, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The TalkingParents team earned its 11th award s
NEW YORK & TORONTO--(BUSINESS WIRE)-- #Advertising--Klick Health is capping off The One Club's Creat
Accolade Core and the Core Six Framework Give Innovation Leaders the Tools to Deliver Measurable Bus
Pernod Ricard has completed the sale of its international wine portfolio, including brands like Jaco
Transcarent on Tuesday announced it has completed its $621 million acquisition of Accolade. Accolade
SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)-- #HealthWayFinding--Today Transcarent announced the succes
SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockhold
Partnership increases access to specialized, whole-person clinical care for people managing digestiv
Here is how Accolade (ACCD) and Casella (CWST) have performed compared to their sector so far this y
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
SAN FRANCISCO and SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health a
Effort broadens healthcare access and removes barriers to primary care and weight management service
NEW YORK , Jan. 10, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law v
Accolade (ACCD) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimat
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th
Transcarent agreed to buy Accolade Inc ACCD Wednesday for $621 million.
During Thursday, 849 stocks hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.